"Superoxide Dismutase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide.
| Descriptor ID |
D013482
|
| MeSH Number(s) |
D08.811.682.881
|
| Concept/Terms |
Ag-Zn Superoxide Dismutase- Ag-Zn Superoxide Dismutase
- Ag Zn Superoxide Dismutase
- Dismutase, Ag-Zn Superoxide
- Superoxide Dismutase, Ag-Zn
Mn-Superoxide Dismutase- Mn-Superoxide Dismutase
- Dismutase, Mn-Superoxide
- Mn Superoxide Dismutase
- Manganese Superoxide Dismutase
- Dismutase, Manganese Superoxide
- Superoxide Dismutase, Manganese
- Mn-SOD
- Mn SOD
Fe-Zn Superoxide Dismutase- Fe-Zn Superoxide Dismutase
- Dismutase, Fe-Zn Superoxide
- Fe Zn Superoxide Dismutase
- Superoxide Dismutase, Fe-Zn
Iron Superoxide Dismutase- Iron Superoxide Dismutase
- Dismutase, Iron Superoxide
- Superoxide Dismutase, Iron
- Fe-Superoxide Dismutase
- Dismutase, Fe-Superoxide
- Fe Superoxide Dismutase
|
Below are MeSH descriptors whose meaning is more general than "Superoxide Dismutase".
Below are MeSH descriptors whose meaning is more specific than "Superoxide Dismutase".
This graph shows the total number of publications written about "Superoxide Dismutase" by people in this website by year, and whether "Superoxide Dismutase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Superoxide Dismutase" by people in Profiles.
-
Polycystic Ovarian Condition May Be a Risk Factor for Ovarian Tumor Development in the Laying Hen Model of Spontaneous Ovarian Cancer. J Immunol Res. 2018; 2018:2590910.
-
Structural and functional properties of bone are compromised in amyotrophic lateral sclerosis mice. Amyotroph Lateral Scler Frontotemporal Degener. 2018 08; 19(5-6):457-462.
-
Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2016 Mar-Apr; 28(2):41-5.
-
Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Mol Carcinog. 2014 Nov; 53(11):907-16.
-
Ischemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity. Stem Cells Dev. 2013 Sep 15; 22(18):2497-507.
-
Selenium enrichment on Cordyceps militaris link and analysis on its main active components. Appl Biochem Biotechnol. 2012 Mar; 166(5):1215-24.
-
Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One. 2011; 6(8):e23354.
-
Signal transduction and oxidative processes in sinonasal polyposis. J Allergy Clin Immunol. 2007 Dec; 120(6):1346-53.
-
Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res. 2007 Aug 01; 67(15):7439-49.
-
Cis-parinaric acid effects, cytotoxicity, c-Jun N-terminal protein kinase, forkhead transcription factor and Mn-SOD differentially in malignant and normal astrocytes. Neurochem Res. 2007 Jan; 32(1):115-24.